发明名称 METHODS AND FORMULATIONS WHICH ALLOW THE MODULATION OF IMMUNE RESPONSES RELATED TO THE ADMINISTRATION OF A BIOPHARMACEUTICAL DRUG
摘要 The present invention is related to methods of preparing a pharmaceutical formulation comprising a biopharmaceutical drug, which methods allows the modulation of immune responses related to the administration thereof. The formulation comprises a buffer comprising hexanedioic acid or at least one salt thereof, and/or citric acid or at least one salt thereof. The present invention further relates to method of using hexanedioic acid or at least one salt thereof, and/or citric acid or at least one salt thereof, to modulate the immunogenicity of a pharmaceutical formulation, to a pharmaceutical formulation as such, and to methods of modulating or determining immune responses related to the administration of a pharmaceutical formulation (FIG. 4).
申请公布号 US2016151484(A1) 申请公布日期 2016.06.02
申请号 US201414905689 申请日期 2014.07.21
申请人 HEXAL AG 发明人 KRONTHALER Ulrich;VIERTLBÖCK-SCHUDY Margot;BARON Melanie
分类号 A61K39/39;A61K39/395;A61K9/19;C07K16/24;A61K9/00 主分类号 A61K39/39
代理机构 代理人
主权项 1. A method of preparing a pharmaceutical formulation comprising a biopharmaceutical drug, which method allows the modulation of immune responses related to the administration thereof, said method comprising the steps of: (i) providing a buffer comprising hexanedioic acid or at least one salt thereof, and/orcitric acid or at least one salt thereof (ii) contacting said buffer with a biopharmaceutical drug (iii) optionally lyophilising the formulation, and (iv) obtaining the formulation or suspension of (ii) and/or the lyophilised formulation of (iii).
地址 Holzkirchen DE